bioAffinity Technologies, Inc. (BIAF)
2.15
+0.22
(+11.40%)
USD |
NASDAQ |
Nov 18, 16:00
2.08
-0.07
(-3.26%)
After-Hours: 20:00
bioAffinity Technologies EPS Diluted (Quarterly) : -5.888 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -5.888 |
| June 30, 2026 | -9.660 |
| March 31, 2026 | -12.12 |
| December 31, 2025 | -10.46 |
| September 30, 2025 | -71.05 |
| June 30, 2025 | -76.07 |
| March 31, 2025 | -73.64 |
| December 31, 2024 | -92.31 |
| September 30, 2024 | -72.66 |
| June 30, 2024 | -83.38 |
| March 31, 2024 | -89.03 |
| December 31, 2023 | -115.51 |
| Date | Value |
|---|---|
| September 30, 2023 | -118.54 |
| June 30, 2023 | -91.90 |
| March 31, 2023 | -81.79 |
| December 31, 2022 | -89.91 |
| September 30, 2022 | -264.50 |
| June 30, 2022 | -5.373 |
| March 31, 2022 | -89.79 |
| December 31, 2021 | -340.16 |
| September 30, 2021 | -92.34 |
| June 30, 2021 | 90.30 |
| March 31, 2021 | -43.68 |
| December 31, 2020 | -130.31 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.0232 |
| Perspective Therapeutics, Inc. | -0.2687 |
| MiMedx Group, Inc. | -0.0595 |
| Veracyte, Inc. | 0.3805 |
| T2 Biosystems, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.277M |
| Revenue (Quarterly) | 1.070M |
| Total Expenses (Quarterly) | 6.347M |
| Enterprise Value | 1.456M |
| Gross Profit Margin (Quarterly) | -10.34% |
| Profit Margin (Quarterly) | -493.0% |
| Earnings Yield | -1.77K% |
| Normalized Earnings Yield | -1709.68 |